Zheng Kai, Yu Xiuchun, Xu Ming, Cui Haocheng, Chen Qian
Department of Orthopedics, 960th Hospital of the People's Liberation Army (PLA), Jinan, China.
Front Oncol. 2025 May 15;15:1554799. doi: 10.3389/fonc.2025.1554799. eCollection 2025.
Joint preservation limb salvage (JPLS) has benefited from advancements in tumor imaging and precision surgical technologies. However, discrepancies exist between the anticipated outcomes of surgical designs and actual clinical results. This study aims to provide a clearer understanding of JPLS.
A systematic search was conducted across the MEDLINE, Embase, and Cochrane Library databases from January 1, 2003, to December 31, 2023. The search utilized the following keywords: "osteosarcoma," "bone tumor," "limb salvage surgery," "surgery," "operation," and "knee." Inclusion criteria were: (1) publication of original studies in English; (2) clinical research pertaining to JPLS; and (3) studies offering detailed individual patient information.
Ultimately, 25 articles encompassing 224 patients were included. The mean age at diagnosis was 16.8 years (range 2-59 years), with the peak incidence occurring between 9 and 18 years. Male patients predominated, with a male-to-female ratio of 1.46:1. Osteosarcomas were primarily located in the distal femur (170 cases) and proximal tibia (54 cases). Resection lengths were documented for 152 patients, averaging 167.6 mm (range 55-396 mm). Notably, reconstruction methods varied: 76 patients received allograft repair, 90 underwent inactivated tumor bone replantation, and 23 patients had autologous bone reconstruction. Additionally, 35 patients underwent prosthetic reconstruction, with 17 receiving traditionally manufactured customized prostheses and 18 utilizing 3D-printed prostheses. The average Musculoskeletal Tumor Society (MSTS) score for limb function was 26.7 points. Twelve patients experienced local tumor recurrence, 39 succumbed to tumor progression, and there were 96 non-oncological complications, predominantly fractures, infections, and bone nonunion.
This review underscores the clinical efficacy of JPLS and examines tumor resection methods, reconstruction techniques, and associated complications.
保肢保关节手术(JPLS)受益于肿瘤成像和精准手术技术的进步。然而,手术设计的预期结果与实际临床结果之间存在差异。本研究旨在更清晰地了解JPLS。
于2003年1月1日至2023年12月31日在MEDLINE、Embase和Cochrane图书馆数据库中进行系统检索。检索使用了以下关键词:“骨肉瘤”、“骨肿瘤”、“保肢手术”、“手术”、“操作”和“膝关节”。纳入标准为:(1)以英文发表的原创研究;(2)与JPLS相关的临床研究;(3)提供详细个体患者信息的研究。
最终纳入25篇文章,共224例患者。诊断时的平均年龄为16.8岁(范围2至59岁),发病高峰在9至18岁之间。男性患者居多,男女比例为1.46:1。骨肉瘤主要位于股骨远端(170例)和胫骨近端(54例)。记录了152例患者的切除长度,平均为167.6毫米(范围55至396毫米)。值得注意的是,重建方法各不相同:76例患者接受同种异体移植修复,90例进行灭活肿瘤骨再植,23例患者进行自体骨重建。此外,35例患者接受假体重建,其中17例接受传统制造的定制假体,18例使用3D打印假体。肢体功能的平均肌肉骨骼肿瘤学会(MSTS)评分为26.7分。12例患者出现局部肿瘤复发,39例死于肿瘤进展,还有96例非肿瘤性并发症,主要为骨折、感染和骨不连。
本综述强调了JPLS的临床疗效,并探讨了肿瘤切除方法、重建技术及相关并发症。